(Q33597696)

28 July 2017

1 reference

title

Serum TSH determinations in pregnancy: how, when and why? (English)

1 reference

28 July 2017

Daniel Glinoer

1

1 reference

PubMed ID

20531379

28 July 2017

Carole A Spencer

series ordinal

2

1 reference

28 July 2017

8 June 2010

1 reference

Nature Reviews Endocrinology

28 July 2017

1 reference

28 July 2017

6

1 reference

28 July 2017

9

1 reference

28 July 2017

526-529

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2010.91

28 July 2017

0 references

cites work

Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Subclinical hyperthyroidism and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Subclinical hypothyroidism and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Applications of a new chemiluminometric thyrotropin assay to subnormal measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Are detection and treatment of thyroid insufficiency in pregnancy feasible?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

The evidence for a narrower thyrotropin reference range is compelling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Circulating thyroid stimulating hormones: why, when, and what to measure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Regulation of maternal thyroid during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Method specific second-trimester reference intervals for thyroid-stimulating hormone and free thyroxine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Thyroid disorders during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Screening for thyroid disease in pregnancy: an audit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Detection of Thyroid Dysfunction in Early Pregnancy: Universal Screening or Targeted High-Risk Case Finding?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Controversies surrounding pregnancy, maternal thyroid status, and fetal outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Overt and subclinical hypothyroidism complicating pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.91

The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20531379

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20531379

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2010.91

1 reference

28 July 2017

1 reference

PubMed ID

20531379